Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors
- 23 February 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (4) , 1043-1048
- https://doi.org/10.1016/j.bmcl.2003.11.076
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Protein tyrosine phosphatase 1B inhibitors for diabetesNature Reviews Drug Discovery, 2002
- PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic miceProceedings of the National Academy of Sciences, 2002
- Protein tyrosine phosphatase-1B in diabetesBiochemical Pharmacology, 2000
- Increased Insulin Sensitivity and Obesity Resistance in Mice Lacking the Protein Tyrosine Phosphatase-1B GeneScience, 1999
- Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.Journal of Clinical Investigation, 1997
- Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of InsulinJournal of Biological Chemistry, 1997
- Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated SignalingJournal of Biological Chemistry, 1996
- Osmotic Loading of Neutralizing Antibodies Demonstrates a Role for Protein-tyrosine Phosphatase 1B in Negative Regulation of the Insulin Action PathwayJournal of Biological Chemistry, 1995
- Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.Journal of Clinical Investigation, 1995
- Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance.Journal of Clinical Investigation, 1994